Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature
- PMID: 28449971
- DOI: 10.1016/j.vaccine.2017.04.032
Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature
Abstract
Background: Pneumococcal diseases are major causes of morbidity among adults, especially those over 50years of age. While pneumococcal conjugated vaccines (PCV's) impact on pneumococcal disease rates among children is well established, the extent of its impact on adult pneumococcal related illness remains unclear. The aim of this systematic literature review was to describe the impact of PCV introduction to childhood national immunization programs worldwide on PCV-naive adult population.
Methods: A systematic literature search was performed using the PubMed database. The search was limited to articles written in English and published between January 2000 and February 2016. Studies evaluating pneumococcal disease rates in individuals over 5years of age were included. Independent extraction of articles was performed by the two authors. Search terms included: Pneumococcal conjugated vaccine, herd, indirect, adults, and pneumonia.
Results: Forty-nine articles meeting the selection criteria were identified, 39 regarding invasive pneumococcal disease (IPD, one on meningitis only), 8 regarding pneumonia, and 2 on both IPD and pneumonia. The majority of reports were from the US, UK and Canada. Considerable variability in the data sources, quality and completeness was observed. While most studies reported either statistically significant reduction or insignificant changes in IPD and pneumonia disease rates in adults following PCV nationwide implementation, few studies reported statistically significant increase in pneumococcal disease rates, these were mainly from countries with low PCV coverage rates and/or inadequate surveillance.
Conclusion: Invasive pneumococcal diseases and pneumonia rates among the adult population decreased in most countries following PCV introduction into the NIP. This indirect effect on older population seems to be dependent on PCV coverage rates and time from PCV nationwide implementation. Adults >65years old seem to benefit the most from PCV introduction.
Keywords: Herd protection; Indirect immunity; Invasive pneumococcal disease (IPD); Pneumococcal conjugated vaccine (PCV); Pneumonia.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
The worldwide impact of the seven-valent pneumococcal conjugate vaccine.Pediatr Infect Dis J. 2012 May;31(5):501-8. doi: 10.1097/INF.0b013e31824de9f6. Pediatr Infect Dis J. 2012. PMID: 22327872
-
Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis.Hum Vaccin Immunother. 2016;12(2):285-92. doi: 10.1080/21645515.2015.1117713. Hum Vaccin Immunother. 2016. PMID: 26905679 Free PMC article.
-
Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children.BMC Infect Dis. 2016 Aug 9;16:390. doi: 10.1186/s12879-016-1693-x. BMC Infect Dis. 2016. PMID: 27506837 Free PMC article.
-
Indirect protection in adults ≥18 years of age from pediatric pneumococcal vaccination: a review.Expert Rev Vaccines. 2024 Jan-Dec;23(1):997-1010. doi: 10.1080/14760584.2024.2416229. Epub 2024 Oct 28. Expert Rev Vaccines. 2024. PMID: 39435466 Review.
-
Disparities in PCV impact between different ethnic populations cohabiting in the same region: A systematic review of the literature.Vaccine. 2016 Aug 17;34(37):4371-7. doi: 10.1016/j.vaccine.2016.07.004. Epub 2016 Jul 18. Vaccine. 2016. PMID: 27443591 Review.
Cited by
-
Decreased relative risk of pneumococcal pneumonia during the last decade, a nested case-control study.Pneumonia (Nathan). 2018 Sep 25;10:9. doi: 10.1186/s41479-018-0053-6. eCollection 2018. Pneumonia (Nathan). 2018. PMID: 30263884 Free PMC article.
-
Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly.PLoS One. 2019 Jan 16;14(1):e0209428. doi: 10.1371/journal.pone.0209428. eCollection 2019. PLoS One. 2019. PMID: 30650091 Free PMC article.
-
Pneumococcal serotypes causing non-invasive pneumonia in adults from a South Indian tertiary care hospital and the impact of the newer conjugate vaccines.Access Microbiol. 2021 Dec 7;3(12):000258. doi: 10.1099/acmi.0.000258. eCollection 2021. Access Microbiol. 2021. PMID: 35024548 Free PMC article.
-
Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study.Lancet. 2019 May 25;393(10186):2146-2154. doi: 10.1016/S0140-6736(18)33005-8. Epub 2019 Apr 15. Lancet. 2019. PMID: 31000194 Free PMC article.
-
Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States.Expert Rev Vaccines. 2019 Apr;18(4):327-341. doi: 10.1080/14760584.2019.1582337. Epub 2019 Mar 20. Expert Rev Vaccines. 2019. PMID: 30759352 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources